Shanghai Huaota Biopharmaceutical Co., Ltd.
Shanghai Huaota Biopharmaceutical Co., Ltd.
Explore linked clinical trials.10 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate Efficacy and Safety of HB0043 in Aadult Patients With Moderate to Severe Acne Vulgaris. | Acneiform Eruptions, Skin and Connective Tissue Diseases, acne, sebaceous gland disorder, skin disorder | Not yet recruiting | Phase 1 / Phase 2 | 2026-03-04 | NCT07449156 | |
| Phase III Clinical Study of HB0025 Combined With Chemotherapy Versus Tislelizumab Combined With Chemotherapy as First-Line Treatment for Advanced Nonsquamous Non-Small Cell Lung Cancer | Non Squamous Non-small Cell Lung Cancer | Not yet recruiting | Phase 3 | 2026-02-03 | NCT07383116 | |
| Phase III Clinical Study of HB0025 Combined With Chemotherapy Versus Pembrolizumab Combined With Chemotherapy for the First-Line Treatment of Advanced Squamous Non-Small Cell Lung Cancer | Squamous Non-small Cell Lung Cancer | Not yet recruiting | Phase 3 | 2026-01-22 | NCT07360132 | |
| Efficacy, Safety, and Tolerability of HB0043 in Hidradenitis Suppurativa Patients. | Bacterial Infections and Mycoses, Infections, Skin and Connective Tissue Diseases, Suppuration, bacterial infectious disease, hidradenitis, hidradenitis suppurativa, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, sweat gland disorder | Recruiting | Phase 1 / Phase 2 | 2026-01-07 | NCT06895499 | |
| A Study to Evaluate Single-dose of HB0056 in Healthy Adult Participants | Healthy | Recruiting | Phase 1 | 2025-09-08 | NCT06612970 | |
| A Study to Evaluate the Safety and Efficacy of HB0052 in Patients With Advanced Solid Tumors | Solid Tumors | Enrolling by invitation | Phase 1 / Phase 2 | 2025-05-28 | NCT06992687 | |
| Efficacy and Safety of HB0034 in Patients with Generalized Pustular Psoriasis (GPP) | Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, psoriasis, skin disorder | Recruiting | Phase 2 | 2025-03-19 | NCT06231381 | |
| A Study to Evaluate the Safety and Efficacy of HB0025 Injection in Patients With Advanced Solid Tumor | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorder | Recruiting | Phase 1 / Phase 2 | 2025-01-23 | NCT06758557 | |
| A Study to Evaluate HB0034 in Healthy Chinese Adult Participants | Healthy | Recruiting | Phase 1 | 2025-01-20 | NCT06716151 | |
| A Study Evaluating the Safety and Efficacy of HB0036 in Subjects With Advanced Solid Tumors | non-small cell lung carcinoma | Recruiting | Phase 1 / Phase 2 | 2025-01-03 | NCT05417321 |